Work with Susanne Haga, Ph.D | NotedSource
I have more than 25 years of research and consulting
experience focused on issues affecting the translation of
genomics to clinical practice, particularly for
pharmacogenetic testing. Specifically, I have substantial
experience in writing and education, with each of my
research projects involving some component of
professional, public or patient education, including
development of educational materials about genomic
research in general, and communicating genetic test
results. In addition, I have been an undergraduate
instructor for several classes including ethical issues in
genomics research, genome technologies & applications,
synthetic genomics, and pharmacogenomics.
https://cv.notedsource.io/me/7XLQ9QML
Susanne Haga, Ph.D
Professor of Medicine at Duke University with experiencein implementation of pharmacogenetic and other genetic tests and patient/provider education
Stafford, Virginia, United States of
America
Research Expertise
Pharmacogenetics
Genetic Testing
Patient and Provider Education
Implementation Sciences
Bioethic
About
I have more than 25 years of research and
consulting experience focused on issues
affecting the translation of genomics to
clinical practice, particularly for
pharmacogenetic testing. Specifically, I have
substantial experience in writing and
education, with each of my research projects
involving some component of professional,
public or patient education, including
development of educational materials about
genomic research in general, and communicating
genetic test results. In addition, I have been
an undergraduate instructor for several
classes including ethical issues in genomics
research, genome technologies &
applications, synthetic genomics, and
pharmacogenomics.
Legacy Map
Full ViewPublications
Reconsidering the family history in
primary care
Journal of General Internal
Medicine
2004
Primary care physicians' knowledge of and
experience with pharmacogenetic testing
Clinical Genetics
2012
Public Knowledge of and Attitudes Toward
Genetics and Genetic Testing
Genetic Testing and Molecular
Biomarkers
2013
Genomic profiling to promote a healthy
lifestyle: not ready for prime time
Nature Genetics
2003
Ethical, Legal, and Social Implications of
Biobanks for Genetics Research
Genetic Dissection of Complex
Traits
2008
Survey of US public attitudes toward
pharmacogenetic testing
The Pharmacogenomics Journal
2011
Handbook of Human Tissue Sources: A
National Resource of Human Tissue Samples
Unknown Venue
1999
Impact of limited population diversity of
genome-wide association studies
Genetics in Medicine
2010
Insurance Coverage Policies for
Personalized Medicine
Journal of Personalized Medicine
2012
Primary Care Physicians’ Knowledge,
Attitudes, and Experience with Personal
Genetic Testing
Journal of Personalized Medicine
2019
BP1, a new homeobox gene, is frequently
expressed in acute leukemias
Leukemia
2000
Clinical delivery of pharmacogenetic
testing services: a proposed partnership
between genetic counselors and pharmacists
Pharmacogenomics
2013
Public Perspectives on Returning Genetics
and Genomics Research Results
Public Health Genomics
2011
Translating genomic biomarkers into
clinically useful diagnostics
Expert Review of Molecular
Diagnostics
2006
Genomic Risk Profiling: Attitudes and Use
in Personal and Clinical Care of Primary
Care Physicians Who Offer Risk Profiling
Journal of General Internal
Medicine
2011
Developing patient-friendly genetic and
genomic test reports: formats to promote
patient engagement and understanding
Genome Medicine
2014
The potential impact of pharmacogenetic
testing on medication adherence
The Pharmacogenomics Journal
2013
BP1, a Homeodomain-Containing Isoform of
DLX4, Represses the β-Globin Gene
Molecular and Cellular Biology
2002
Pharmacogenetic testing: not as simple as
it seems
Genetics in Medicine
2008
Managing incidental genomic findings:
legal obligations of clinicians
Genetics in Medicine
2013
Public Perspectives About Pharmacogenetic
Testing and Managing Ancillary Findings
Genetic Testing and Molecular
Biomarkers
2012
Public Perspectives Regarding Data-Sharing
Practices in Genomics Research
Public Health Genomics
2011
FDA Races in Wrong Direction
Science
2003
Professional Perspectives About
Pharmacogenetic Testing and Managing
Ancillary Findings
Genetic Testing and Molecular
Biomarkers
2012
Using Pharmacogenetics to Improve Drug
Safety and Efficacy
JAMA
2004
Survey of genetic counselors and clinical
geneticists' use and attitudes toward
pharmacogenetic testing
Clinical Genetics
2012
Adding pharmacogenetics information to
drug labels: lessons learned
Pharmacogenetics and Genomics
2006
Distinct functions of two isoforms of a
homeobox gene, BP1 and DLX7, in the
regulation of the β-globin gene
Gene
2001
Horizon Scan Of Clinical Laboratories
Offering Pharmacogenetic Testing
Health Affairs
2018
Comparison of delivery strategies for
pharmacogenetic testing services
Pharmacogenetics and Genomics
2014
Public attitudes toward ancillary
information revealed by pharmacogenetic
testing under limited information
conditions
Genetics in Medicine
2011
Effect of genetic testing for risk of type
2 diabetes mellitus on health behaviors
and outcomes: study rationale, development
and design
BMC Health Services Research
2012
Community pharmacists’ experience with
pharmacogenetic testing
Journal of the American Pharmacists
Association
2015
Patient experiences with pharmacogenetic
testing in a primary care setting
Pharmacogenomics
2016
Pharmacogenetic testing: current evidence
of clinical utility
Therapeutic Advances in Drug
Safety
2013
Teaching resources for genetics
Nature Reviews Genetics
2006
Delivering pharmacogenetic testing in a
primary care setting
Pharmacogenomics and Personalized
Medicine
2013
Incorporation of pharmacogenetic testing
into medication therapy management
Pharmacogenomics
2015
Effects of Delivering
SLCO1B1
Pharmacogenetic Information in Randomized
Trial and Observational Settings
Circulation: Genomic and Precision
Medicine
2018
Researcher Practices on Returning Genetic
Research Results
Genetic Testing and Molecular
Biomarkers
2010
EDITORIAL BOARD
Race Ethnicity and Education
2012
Genetically Guided Statin Therapy on
Statin Perceptions, Adherence, and
Cholesterol Lowering: A Pilot
Implementation Study in Primary Care
Patients
Journal of Personalized Medicine
2014
Defining the spectrum of genome policy
Nature Reviews Genetics
2006
Genomic Counseling: Next Generation
Counseling
Journal of Genetic Counseling
2013
Factors Influencing Uptake of
Pharmacogenetic Testing in a Diverse
Patient Population
Public Health Genomics
2009
Binding of HMG-I(Y) elicits structural
changes in a silencer of the human
?-globin gene
American Journal of Hematology
1999
Access to Genetic Counselors in the
Southern United States
Journal of Personalized Medicine
2019
Primary-care physicians’ access to genetic
specialists: an impediment to the
routine use of genomic medicine?
Genetics in Medicine
2013
Challenges of development and
implementation of point of care
pharmacogenetic testing
Expert Review of Molecular
Diagnostics
2016
Impact of Delivery Models on Understanding
Genomic Risk for Type 2 Diabetes
Public Health Genomics
2014
Considerations for the Impact of Personal
Genome Information: A Study of Genomic
Profiling among Genetics and Genomics
Professionals
Journal of Genetic Counseling
2010
Pharmacogenomics courses in pharmacy
school curricula
Pharmacogenomics
2019
Pilot study of pharmacist-assisted
delivery of pharmacogenetic testing in a
primary care setting
Pharmacogenomics
2014
Challenges to Integrating Pharmacogenetic
Testing into Medication Therapy Management
Journal of Managed Care & Specialty
Pharmacy
2015
A stepwise approach to implementing
pharmacogenetic testing in the primary
care setting
Pharmacogenomics
2019
Striking a balance in communicating
pharmacogenetic test results: Promoting
comprehension and minimizing adverse
psychological and behavioral response
Patient Education and Counseling
2014
Primary care providers’ use of pharmacist
support for delivery of pharmacogenetic
testing
Pharmacogenomics
2017
The Potential of a Placebo/Nocebo Effect
in Pharmacogenetics
Public Health Genomics
2009
Consideration of patient preferences and
challenges in storage and access of
pharmacogenetic test results
Genetics in Medicine
2011
Clinical Utilization of Pharmacogenetics
in Psychiatry – Perspectives of
Pharmacists, Genetic Counselors,
Implementation Science, Clinicians, and
Industry
Pharmacopsychiatry
2019
Enhancing geneticists’ perspectives of the
public through community engagement
Genetics in Medicine
2012
Ethical Issues of Predictive Genetic
Testing for Diabetes
Journal of Diabetes Science and
Technology
2009
Development and Initial Assessment of a
Patient Education Video about
Pharmacogenetics
Journal of Personalized Medicine
2017
A review of consent practices and
perspectives for pharmacogenetic testing
Pharmacogenomics
2016
Information‐Seeking and Sharing Behavior
Following Genomic Testing for Diabetes
Risk
Journal of Genetic Counseling
2014
Evaluation of a pharmacogenetic
educational toolkit for community
pharmacists
Pharmacogenomics
2016
Pharmacogenetic information for patients
on drug labels
Pharmacogenomics and Personalized
Medicine
2014
Stakeholder Views on Returning Research
Results
Advances in Genetics
2013
Promoting Public Awareness and Engagement
in Genome Sciences
Journal of Genetic Counseling
2013
Pilot study: incorporation of
pharmacogenetic testing in medication
therapy management services
Pharmacogenomics
2014
Awareness of family health history in a
predominantly young adult population
PLOS ONE
2019
Clinical and Counseling Experiences of
Early Adopters of Whole Exome Sequencing
Journal of Genetic Counseling
2015
Learning from product labels and label
changes: how to build pharmacogenomics
into drug-development programs
Pharmacogenomics
2010
Prescribing BiDil
Journal of the American College of
Cardiology
2006
Assessing feasibility of delivering
pharmacogenetic testing in a community
pharmacy setting
Pharmacogenomics
2017
<p>Pharmacogenomic Testing In
Pediatrics: Navigating The Ethical,
Social, And Legal Challenges</p>
Pharmacogenomics and Personalized
Medicine
2019
Educating patients and providers through
comprehensive pharmacogenetic test reports
Pharmacogenomics
2017
Analysis of Educational Materials and
Destruction/Opt-Out Initiatives for
Storage and Use of Residual Newborn
Screening Samples
Genetic Testing and Molecular
Biomarkers
2010
Independent Community Pharmacists’
Experience in Offering Pharmacogenetic
Testing
Pharmacogenomics and Personalized
Medicine
2021
Nurses’ communication of pharmacogenetic
test results as part of discharge care
Pharmacogenomics
2015
First Responder to Genomic Information: A
Guide for Primary Care Providers
Molecular Diagnosis & Therapy
2019
Qualitative user evaluation of a revised
pharmacogenetic educational toolkit
Pharmacogenomics and Personalized
Medicine
2018
Integrating pharmacogenetic testing into
primary care
Expert Review of Precision Medicine and
Drug Development
2017
The Potential Benefit of Expedited
Development and Approval Programs in
Precision Medicine
Journal of Personalized Medicine
2021
Toward digital-based interventions for
medication adherence and safety
Expert Opinion on Drug Safety
2020
Ensuring the Safe Use of Genomic Medicine
in Children
Clinical Pediatrics
2009
Evaluating Primary Care Providers’
Readiness for Delivering Genetic and
Genomic Services to Underserved
Populations
Public Health Genomics
2021
Effect of Sociodemographic Factors on
Uptake of a Patient-Facing Information
Technology Family Health History Risk
Assessment Platform
Applied Clinical Informatics
2019
Introducing personalized health for the
family: the experience of a single
hospital system
Pharmacogenomics
2017
Patient Beliefs and Behaviors About
Genomic Risk for Type 2 Diabetes:
Implications for Prevention
Journal of Health Communication
2015
A Systematic Review of the Scope of Study
of mHealth Interventions for Wellness and
Related Challenges in Pediatric and Young
Adult Populations
Adolescent Health, Medicine and
Therapeutics
2022
Revisiting Secondary Information Related
to Pharmacogenetic Testing
Frontiers in Genetics
2021
The enduring importance of family health
history in the era of genomic medicine and
risk assessment
Personalized Medicine
2020
Update: looking beyond the 100,000 Genome
Project
Personalized Medicine
2017
Comparative Effectiveness Research and
Demonstrating Clinical Utility for
Molecular Diagnostic Tests
Clinical Chemistry
2015
Delivering pharmacogenetic testing to the
masses: an achievable goal?
Pharmacogenomics
2014
Genetic Testing: Clinical and Personal
Utility
AMA Journal of Ethics
2012
Practical Ethics: Establishing a Pathway
to Benefit for Complex Pharmacogenomic
Tests
Clinical Pharmacology &
Therapeutics
2011
Letting the Genome Out of the Bottle
New England Journal of Medicine
2008
The Critical Role of Pharmacists in the
Clinical Delivery of Pharmacogenetics in
the U.S
Pharmacy
2023
Expanding Family Health History to Include
Family Medication History
Journal of Personalized Medicine
2023
Education
Western Maryland College
BA, Biology/Chemistry / May, 1994
Westminster, Maryland, United
States of America
University of Maryland, Baltimore
Ph.D., Human Genetics / May, 1999
Baltimore, Maryland, United States
of America
Experience
School of Medicine, Duke University
Professor
Links & Social Media
Join Dr. Haga on NotedSource!
Join Now
At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.
For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.
For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.
Expert Institutions
Proudly trusted by
